Bachem Holding (Suzhou): difference between revisions
Diff·revision 19 → 20·22:01, 15 Dec 2024
Difference between revision 19 and revision 20 of Bachem Holding (Suzhou). 3 lines changed; the page grew by 466 bytes.
| Revision 19 — 08:01, 10 Dec 2024 VerifyFirstVida (talk) reorder sections to follow the class template 4,989 bytes +159 | Revision 20 — 22:01, 15 Dec 2024 StubSorterBot (talk) bot: update parent category chain 5,455 bytes +466 | ||
|---|---|---|---|
| 30 | Purchaser reports describe lyophilised material in crimped vials with a batch certificate reporting purity, appearance and, in most cases, water.{{r|reports}} Packaging has been consistently described as insulated for the temperature-sensitive lines. | 30 | Purchaser reports describe lyophilised material in crimped vials with a batch certificate reporting purity, appearance and, in most cases, water.{{r|reports}} Packaging has been consistently described as insulated for the temperature-sensitive lines. |
| 31 | 31 | ||
| + | 32 | The organisation's own material makes claims about quality systems that this wiki has not corroborated. A GMP claim in particular is not a fact until assessed against the applicable framework, and no assessment is available here.{{r|gmp,selfpub}} | |
| + | 33 | ||
| 32 | == References == | 34 | == References == |
| 33 | {{reflist}} | 35 | {{reflist}} |
| ⋮ | ⋮ | ||
| 37 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 39 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| 38 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 40 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| + | 41 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | |
| 39 | 42 | ||
| 40 | {{DEFAULTSORT:Bachem Holding (Suzhou)}} | 43 | {{DEFAULTSORT:Bachem Holding (Suzhou)}} |